Focus on Inpatient Diabetes Management: Optimizing Glycemic Control
CARLOS R. HAMILTON, JR., MD, FACE
Professor of Internal medicine
University of Texas Houston Medical School
Carlos R. Hamilton, Jr., MD, FACE, has practiced clinical endocrinology and internal medicine, and he is the executive vice president of the University of Texas Health Science Center at Houston and a professor of internal medicine at the UT Houston Medical School. After graduating from Baylor College of Medicine, he completed his internship and residency at the Johns Hopkins Hospital, an endocrine fellowship at the Massachusetts General Hospital, and was chief resident in medicine at Hopkins. He was on the full-time faculty at Hopkins before serving two years as an endocrinologist at the Wilford Hall USAF Medical Center in San Antonio. He was in private practice for 26 years and was a clinical professor of medicine at Baylor College of Medicine before assuming his present position.
Dr. Hamilton has been active in medical organizations primarily as an advocate for medical practice and patient's rights. He has been a member of the AACE board of directors and served as chair of the AACE legislative and regulatory committee. He has also served as president of the Texas Society of Internal Medicine, the Harris County Medical Society and as chair of the Texas Medical Association Political Action Committee. He has served as a trustee of the American Society of Internal Medicine, as a member of the ACP-ASIM Health and Public Policy Committee and as a member of the AMA Federation Advisory Committee. He served as the 2004–2005 AACE president and as a trustee of the American College of Endocrinology. He is a past president on the AACE board of directors and president-elect of the American College of Endocrinology. He is a member of the practicing physicians advisory council to the US Secretary of Health and Human Services for issues related to the Center of Medicare and Medicaid Services. He also serves on the health, medicine and research committee of the World Anti-Doping Agency, which oversees the international prohibitions of the use of hormones and performance enhancing substances in athletic competition.
University of California in Los Angeles
Dr. Etie Moghissi is a member of the Board of Directors of the American Association of Clinical Endocrinologists (AACE) and the Immediate Past President of the California Chapter of the AACE. She is the co- chair of AACE Inpatients Diabetes Taskforce and serves as the co-chair of the American College of Endocrinology's (ACE) Consensus Development Conference on Inpatient Diabetes and Metabolic Control.
Board certified in internal medicine and endocrinology, Dr. Moghissi is in private practice in Inglewood, California, where she is the Medical Director of the Diabetes Care Center the Weight Management Program at Cantilena Freeman Health System in Inglewood and Marina Del-Ray, California
From 1990 to 2004 she held a position of Clinical Associate Professor of Medicine at the University of Southern California.
A graduate of Pahlavi University and Pahlavi University Medical School in Shiraz, Iran, Dr. Moghissi completed residency at both Namazee Hospital in Shiraz, Iran, and St. Luke's Roosevelt Hospital at Columbia University in NYC. She completed her fellowship in endocrinology at the University of Southern California.
A Charter Member of the AACE, she has served on several task forces, including the Endocrine Education for PCP, the In-Patient Diabetes Consensus Conference, and the Intensive Insulin Management Guidelines. Dr. Moghissi has participated in several AACE committees, including the Annual Meeting Clinical Congress Program Committee, Chapters Steering Committee, and the Nominating Committee.
Director Oregon Health & Science University Diabetes Center
Portland, Oregon.
Andrew J. Ahmann, MD, is associate professor of medicine and director of the Oregon Health & Science University (OHSU) Diabetes Center in Portland, Oregon. He also serves as director of adult diabetes services at the university. He is a diplomat of the National Board of Medical Examiners, American Board of Internal Medicine, and American Board of Endocrinology and Metabolism.
After earning an MS Degree in Pharmacy, Dr Ahmann earned his medical degree at the University of Colorado School of Medicine. He completed an internal medicine internship and residency at Fitzsimons Army Medical Center, Denver, Colorado, and subsequently performed fellowships in both endocrinology and endocrinology research at Walter Reed Army Medical Center in Washington, DC.
A present member of the American Diabetes Association (ADA) National Professional Practice Committee, Dr Ahmann is also president of the ADA Portland Area Leadership Council. He served as the founding co-chair of the Oregon Diabetes Coalition and the chair of the Oregon Diabetes Collaborative. He serves as the chairman of the Oregon Diabetes Guidelines Committee. Dr. Ahmann was a member of the ADA Writing Committee for Inpatient Diabetes Management in 1993/94. He was also a Task Force member of the AACE for the Consensus Development Conference on Inpatient Diabetes and Metabolic Control in December 2003. Other relevant national activities include faculty participation in the ADA grand rounds program on “Insulin Therapy in the Hospital” and participation in the Glycemic Control Task Force of the Society of Hospital Medicine, developing a web-based comprehensive manual for guiding inpatient diabetes programs.